PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 112 filers reported holding PULMONX CORP in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,739,292 | -21.2% | 652,400 | 0.0% | 0.18% | -10.8% |
| Q2 2023 | $8,552,964 | +17.3% | 652,400 | 0.0% | 0.20% | +16.7% |
| Q1 2023 | $7,293,832 | +32.6% | 652,400 | 0.0% | 0.17% | +31.8% |
| Q4 2022 | $5,499,732 | -44.7% | 652,400 | +9.2% | 0.13% | -48.6% |
| Q3 2022 | $9,953,000 | -3.7% | 597,400 | -14.9% | 0.26% | -14.6% |
| Q2 2022 | $10,339,000 | -40.7% | 702,400 | 0.0% | 0.30% | -31.4% |
| Q1 2022 | $17,427,000 | -22.4% | 702,400 | +0.3% | 0.44% | -15.4% |
| Q4 2021 | $22,449,000 | -10.9% | 700,000 | 0.0% | 0.52% | -2.1% |
| Q3 2021 | $25,186,000 | -3.7% | 700,000 | +18.1% | 0.53% | +2.5% |
| Q2 2021 | $26,141,000 | -3.5% | 592,500 | 0.0% | 0.52% | -12.5% |
| Q1 2021 | $27,101,000 | -21.5% | 592,500 | +18.5% | 0.59% | -19.3% |
| Q4 2020 | $34,510,000 | – | 500,000 | – | 0.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $886,000 | 3.13% |
| PURA VIDA INVESTMENTS, LLC | 1,327,065 | $19,534,000 | 1.13% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,465,901 | $51,018,000 | 1.05% |
| NEXT CENTURY GROWTH INVESTORS LLC | 453,098 | $6,669,000 | 0.87% |
| Novo Holdings A/S | 510,555 | $7,515,000 | 0.37% |
| Rock Springs Capital Management LP | 702,400 | $10,339,000 | 0.30% |
| RTW INVESTMENTS, LP | 691,255 | $10,175,000 | 0.26% |
| TimesSquare Capital Management, LLC | 1,214,204 | $17,873,000 | 0.25% |
| FORMULA GROWTH LTD | 54,951 | $809,000 | 0.22% |
| Champlain Investment Partners, LLC | 2,129,760 | $31,350,000 | 0.20% |